Tying our Fate to Molecular Markings
News Oct 16, 2012
In a new study, Emberly and his colleagues at Simon Fraser University cite proof that variable methylation, a chemical mark on our DNA, is predictive of age, gender, stress, cancer and early-life socioeconomic status within a population. The Proceedings of the National Academy of Sciences (PNAS) has just published the study online.
Working with researchers at the University of British Columbia and Stanford University, Eldon Emberly studied the variation of methylation over a large group of individuals.
DNA that is methylated in our genomes is known to affect whether genes are turned on or off. Gene expression predicates several attributes linked to our identity, such as gender, ethnicity, age and health.
The trio measured methylation from DNA in the white blood cells of 92 people aged 24 to 45. Emberly’s lab helped to mine the resulting data sets for correlations between variation in the chemical mark and variable social, psychological and physical traits in the subjects.
The results demonstrated that those who had experienced childhood poverty had a different methylation level from those who hadn’t. This was despite the fact everyone in the cohort had achieved the same socioeconomic status later in life.
That meant that early-life environment had left a detectable molecular mark on an individual’s DNA.
The correlation between methylation and gene expression was complex because it wasn’t always predictable but there was one connection of particular note says Emberly, an SFU associate professor.
“Variable methylation correlated with variable expression of the gene DDX4, which is linked to certain cancers.”
Emberly says this study’s discoveries raise interesting questions, as the connection between methylation and some traits, such as smoking and alcohol consumption, was weaker than expected or non existent.
“We’re now investigating whether methylation variation in different types of tissue is more predictive of some trait,” adds Emberly.
Pau Farre, a master’s of science student in physics under Emberly’s supervision, is doing a statistical analysis of the variability in methylation across tissues.
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Study Indicates 75% of Human Genome is Non-functionalNews
An evolutionary biologist at the University of Houston has published new calculations that indicate no more than 25 percent of the human genome is functional.READ MORE
Edith Heard Unanimously Selected as Next Director General of EMBLNews
At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organization’s fifth Director General. Heard’s mandate is scheduled to begin 1 January 2019.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018